ENTREMED, INC. (NASDAQ:ENMD)
$0.79
0.03 (+3.29%)
| CAPS Rating |
|
|---|---|
| Open | $0.76 |
| Previous Close | $0.76 |
| Daily Range | $0.76 - $0.84 |
| 52-Week Range | $0.17 - $1.53 |
| Market Cap | $70.06M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 408,637 |
| Average Daily Volume | 0 |
ENMD
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ENMD Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ENMD News and Commentary
- Why We Love Wild Penny Stocks – The Motley Fool
- The Best Stocks for the Next 4 Years – The Motley Fool
- Closing ENMD (Entremed) underperform – Blog at The Motley Fool
Related News and Articles
- This Just In: Upgrades and Downgrades – The Motley Fool
- FDA Says "No Way!" Market Says "Yeah, Baby!" – The Motley Fool
- 5 Superball Stocks – The Motley Fool
- 4-Star Stocks Poised to Pop: 3SBio – The Motley Fool
- Is Medivation a Buy? – The Motley Fool
- Up 160% With Room to Run – The Motley Fool
- You Paid How Much for That? – The Motley Fool
- Is Your Dream Stock Really a Nightmare? – The Motley Fool
- Avoid the Shiny Happy Morons – The Motley Fool
- A Big Upgrade for SciClone Pharmaceuticals – The Motley Fool
- You'd Be Stupid to Buy These Stocks – The Motley Fool
- The Opportunity That Wasn't – The Motley Fool
- One Small Cap for the Coming Rally – The Motley Fool
- Pfizer Still Dealing With Antitrust Issues – The Motley Fool
- Really? A 59% Share Price Jump for That? – The Motley Fool
RSS Headlines
Fool UK
